• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病患者心脏组织中铁死亡相关基因的鉴定

Identification of ferroptosis-related genes in heart tissues of patients with hypertrophic cardiomyopathy.

作者信息

Huang Fang, Li Shujuan, Zhang Ailei, Zhao Jihuai, Zhang Shaoqiang, Liu Dongwei, Chen Wei

机构信息

Department of Cardiology, Qingdao West Coast New Area People's Hospital, Cardiovascular Internal Medicine, Qingdao, Shandong, China.

出版信息

Medicine (Baltimore). 2025 Feb 28;104(9):e41525. doi: 10.1097/MD.0000000000041525.

DOI:10.1097/MD.0000000000041525
PMID:40020138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11875581/
Abstract

BACKGROUND

This study aims to investigate the role of ferroptosis in hypertrophic cardiomyopathy (HCM), a genetic disorder characterized by abnormal thickening of the heart muscle. The objective is to identify differentially expressed genes associated with ferroptosis in HCM and understand the potential molecular mechanisms underlying the disease.

METHODS

Comprehensive genomic analysis was conducted to identify differentially expressed genes associated with ferroptosis in HCM. The analysis focused on TFRC, SCD, SLC2A1, EGR1, GDF15, SNCA, PLIN2, and NQO1 as hub genes regulating ferroptosis. Functional enrichment analysis was performed to uncover their involvement in pathways such as ferroptosis, ubiquinone biosynthesis, and HIF-1 signaling. In addition, immune cell infiltration patterns in HCM were explored, and associations between the hub genes and immune infiltration were identified.

RESULTS

The analysis revealed TFRC, SCD, SLC2A1, EGR1, GDF15, SNCA, PLIN2, and NQO1 as hub genes involved in the regulation of ferroptosis in HCM. Functional enrichment analysis indicated their contribution to key pathways related to ferroptosis, ubiquinone biosynthesis, and HIF-1 signaling. Furthermore, associations between the hub genes and immune infiltration in HCM were observed.

CONCLUSION

This study provides valuable insights into the molecular basis of HCM by identifying differentially expressed genes associated with ferroptosis. The findings suggest potential molecular mechanisms underlying the development of HCM. These findings contribute to a better understanding of HCM and may pave the way for the development of targeted therapies and improved diagnostic approaches for this debilitating cardiac disorder.

摘要

背景

本研究旨在探讨铁死亡在肥厚型心肌病(HCM)中的作用,肥厚型心肌病是一种以心肌异常增厚为特征的遗传性疾病。目的是鉴定与肥厚型心肌病中铁死亡相关的差异表达基因,并了解该疾病潜在的分子机制。

方法

进行全面的基因组分析,以鉴定与肥厚型心肌病中铁死亡相关的差异表达基因。分析聚焦于TFRC、SCD、SLC2A1、EGR1、GDF15、SNCA、PLIN2和NQO1等作为调节铁死亡的枢纽基因。进行功能富集分析,以揭示它们参与铁死亡、泛醌生物合成和HIF-1信号传导等途径。此外,还探讨了肥厚型心肌病中的免疫细胞浸润模式,并确定了枢纽基因与免疫浸润之间的关联。

结果

分析显示TFRC、SCD、SLC2A1、EGR1、GDF15、SNCA、PLIN2和NQO1是参与肥厚型心肌病中铁死亡调节的枢纽基因。功能富集分析表明它们对与铁死亡、泛醌生物合成和HIF-1信号传导相关的关键途径有贡献。此外,还观察到了肥厚型心肌病中枢纽基因与免疫浸润之间的关联。

结论

本研究通过鉴定与铁死亡相关的差异表达基因,为肥厚型心肌病的分子基础提供了有价值的见解。这些发现提示了肥厚型心肌病发展的潜在分子机制。这些发现有助于更好地理解肥厚型心肌病,并可能为这种使人衰弱的心脏疾病的靶向治疗和改进诊断方法的开发铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/bf3a8dca024c/medi-104-e41525-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/fa85eedf4c93/medi-104-e41525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/d85b6b0589c1/medi-104-e41525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/8031bd74689f/medi-104-e41525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/8a2a9ffe2802/medi-104-e41525-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/9a93afe4d8db/medi-104-e41525-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/8c9721c764a7/medi-104-e41525-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/bf3a8dca024c/medi-104-e41525-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/fa85eedf4c93/medi-104-e41525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/d85b6b0589c1/medi-104-e41525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/8031bd74689f/medi-104-e41525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/8a2a9ffe2802/medi-104-e41525-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/9a93afe4d8db/medi-104-e41525-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/8c9721c764a7/medi-104-e41525-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce6f/11875581/bf3a8dca024c/medi-104-e41525-g007.jpg

相似文献

1
Identification of ferroptosis-related genes in heart tissues of patients with hypertrophic cardiomyopathy.肥厚型心肌病患者心脏组织中铁死亡相关基因的鉴定
Medicine (Baltimore). 2025 Feb 28;104(9):e41525. doi: 10.1097/MD.0000000000041525.
2
Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy a Microarray Data Analysis.探索扩张型心肌病和肥厚型心肌病的共同发病机制、铁死亡机制及潜在治疗靶点——一项微阵列数据分析
Front Cardiovasc Med. 2022 Feb 24;9:824756. doi: 10.3389/fcvm.2022.824756. eCollection 2022.
3
MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.心肌肥厚症患者 MYBPC3 突变的心脏组织中的 microRNA 转录组谱分析。
J Mol Cell Cardiol. 2013 Dec;65:59-66. doi: 10.1016/j.yjmcc.2013.09.012. Epub 2013 Sep 29.
4
Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy.全面蛋白质组学分析人类心肌组织,揭示肥厚型心肌病中失调的信号通路。
J Am Coll Cardiol. 2024 Nov 12;84(20):1999-2011. doi: 10.1016/j.jacc.2024.07.043. Epub 2024 Oct 2.
5
Identification and validation of pyroptosis-related genes as potential biomarkers for hypertrophic cardiomyopathy: A comprehensive bioinformatics analysis.鉴定和验证细胞焦亡相关基因作为肥厚型心肌病的潜在生物标志物:一项全面的生物信息学分析
Medicine (Baltimore). 2024 Jan 26;103(4):e36799. doi: 10.1097/MD.0000000000036799.
6
Identification and verification of promising diagnostic biomarkers in patients with hypertrophic cardiomyopathy associate with immune cell infiltration characteristics.肥厚型心肌病患者中与免疫细胞浸润特征相关的有前景的诊断生物标志物的识别与验证。
Life Sci. 2021 Nov 15;285:119956. doi: 10.1016/j.lfs.2021.119956. Epub 2021 Sep 11.
7
Identification of biomarkers correlated with hypertrophic cardiomyopathy with co-expression analysis.基于共表达分析鉴定与肥厚型心肌病相关的生物标志物。
J Cell Physiol. 2019 Dec;234(12):21999-22008. doi: 10.1002/jcp.28762. Epub 2019 May 6.
8
The molecular and cellular landscape of hypertrophic cardiomyopathy phenotypes: transition from obstructive to end-stage heart failure.肥厚型心肌病表型的分子和细胞格局:从梗阻性到终末期心力衰竭的转变。
J Mol Med (Berl). 2025 Jan;103(1):113-123. doi: 10.1007/s00109-024-02508-7. Epub 2025 Jan 7.
9
Machine learning-driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy.机器学习驱动的诊断特征为肥厚型心肌病的临床管理提供了新的见解。
ESC Heart Fail. 2024 Aug;11(4):2234-2248. doi: 10.1002/ehf2.14762. Epub 2024 Apr 17.
10
Bioinformatics analysis of ferroptosis-related hub genes and immunoinfiltration in myocardial ischemia/reperfusion following heart transplantation.心脏移植后心肌缺血/再灌注中铁死亡相关枢纽基因及免疫浸润的生物信息学分析
BMC Cardiovasc Disord. 2025 Jan 10;25(1):16. doi: 10.1186/s12872-024-04462-1.

本文引用的文献

1
Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of Guanxin Shutong capsule in treating heart failure.整合网络药理学与实验验证探索冠心舒通胶囊治疗心力衰竭的药理机制。
Medicine (Baltimore). 2024 Oct 18;103(42):e40118. doi: 10.1097/MD.0000000000040118.
2
Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases.心脏中的巨噬细胞在维持心脏稳态和调节心脏疾病的心室重构中的作用。
Front Immunol. 2024 Sep 20;15:1467089. doi: 10.3389/fimmu.2024.1467089. eCollection 2024.
3
Association of Multiple Nonhypertrophic Cardiomyopathy-Related Genetic Variants and Outcomes in Patients With Hypertrophic Cardiomyopathy.
肥厚型心肌病患者中多种非肥厚型心肌病相关基因变异与预后的关联
JACC Heart Fail. 2024 Dec;12(12):2041-2052. doi: 10.1016/j.jchf.2024.08.005. Epub 2024 Sep 25.
4
Cell death pathways: molecular mechanisms and therapeutic targets for cancer.细胞死亡途径:癌症的分子机制与治疗靶点
MedComm (2020). 2024 Sep 4;5(9):e693. doi: 10.1002/mco2.693. eCollection 2024 Sep.
5
Analysis of mechanism, therapeutic strategies, and potential natural compounds against atherosclerosis by targeting iron overload-induced oxidative stress.通过针对铁过载诱导的氧化应激靶向治疗动脉粥样硬化的机制、治疗策略和潜在天然化合物分析。
Biomed Pharmacother. 2024 Aug;177:117112. doi: 10.1016/j.biopha.2024.117112. Epub 2024 Jul 16.
6
Unraveling shared molecular signatures and potential therapeutic targets linking psoriasis and acute myocardial infarction.揭示银屑病和急性心肌梗死之间共享的分子特征和潜在治疗靶点。
Sci Rep. 2024 Jul 16;14(1):16471. doi: 10.1038/s41598-024-67350-w.
7
Ferroptosis in health and disease.铁死亡在健康和疾病中的作用。
Redox Biol. 2024 Sep;75:103211. doi: 10.1016/j.redox.2024.103211. Epub 2024 May 30.
8
Genetic Mutations and Mitochondrial Redox Signaling as Modulating Factors in Hypertrophic Cardiomyopathy: A Scoping Review.遗传突变与线粒体氧化还原信号在肥厚型心肌病中的调节作用:系统评价
Int J Mol Sci. 2024 May 28;25(11):5855. doi: 10.3390/ijms25115855.
9
Principles and therapeutic applications of adaptive immunity.适应性免疫的原理和治疗应用。
Cell. 2024 Apr 25;187(9):2052-2078. doi: 10.1016/j.cell.2024.03.037.
10
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets.心血管系统缺氧诱导信号:发病机制和治疗靶点。
Signal Transduct Target Ther. 2023 Nov 20;8(1):431. doi: 10.1038/s41392-023-01652-9.